User login
Enter your username and password here in order to log in on the website:
Enter your username and password here in order to log in on the website:
SYNLAB BONDCO PLC / SYNLAB UNSECURED BONDCO PLC ("the Company") notes the speculation/press reports concerning the participation of SYNLAB in the South East London Pathology Procurement (OJEU Reference 2018/S 158-362262) being ...
SYNLAB Bondco Plc ("SYNLAB"), the leading provider of medical diagnostic services in Europe, today announced that it successfully closed a term loan transaction amounting to EUR 920 million, maturing in July 2026.
SYNLAB Bondco Plc ("SYNLAB") today announced that it is preparing the launch of a debt refinancing transaction aiming to raise up to an aggregate principal amount of €920,000,000 through a term loan facility, maturing in 2026 ...
SYNLAB Bondco Plc (»SYNLAB« or »the Group«), the leading provider of medical diagnostic services in Europe, today announced that it successfully raised EUR 150 million of incremental debt on its existing Term Loan Facility, ...
The GDN, initiated by US-based Quest Diagnostics, brings together leading diagnostics services providers to share expertise and insights and drive worldwide diagnostics innovation
SYNLAB ("SYNLAB" and “the Group”), the leading medical diagnostic services provider in Europe, announces that the Group acquired 100% of the shares in Yhtyneet Medix Laboratoriot Oy (“YML”), Finland’s leading private laboratory ...
Munich, 10 January 2018 – SYNLAB Group (‘SYNLAB’ or ‘the Group’) the leading European provider of medical diagnostic services, today announces that Dr Bartl Wimmer will retire as Group Chief Executive Officer with effect from 2 ...
Munich, 10 January 2018 – SYNLAB Group (‘SYNLAB’ or ‘the Group’) the leading European provider of medical diagnostic services, today announces that Dr Bartl Wimmer will retire as Group Chief Executive Officer with effect from 2 ...
SYNLAB Bondco Plc ("SYNLAB" or “the Group”), the leading provider of medical diagnostic services in Europe, today announced that it successfully closed a term loan transaction amounting to EUR 300 million, maturing in 2022.
New Chief Business Officer role reflects the need for SYNLAB to address the challenges brought about by the Group’s sustained growth across geographic regions and the increased scope of the businessSYNLAB Group CEO Wimmer: ...